- Home
- HMY vs ASND Comparison
HMY vs ASND Comparison
Compare HMY & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HMY | ASND |
|---|---|---|
| Founded | 1950 | 2006 |
| Country | South Africa | Denmark |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 12.2B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | HMY | ASND |
|---|---|---|
| Price | $20.69 | $200.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 15 |
| Target Price | $16.00 | ★ $256.40 |
| AVG Volume (30 Days) | ★ 4.1M | 794.8K |
| Earning Date | 02-04-2016 | 11-12-2025 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | ★ 67.74 | N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $4,161,584,110.00 | $758,592,045.00 |
| Revenue This Year | $39.51 | $99.74 |
| Revenue Next Year | $14.06 | $79.40 |
| P/E Ratio | $15.72 | ★ N/A |
| Revenue Growth | 20.39 | ★ 97.46 |
| 52 Week Low | $7.97 | $118.03 |
| 52 Week High | $22.25 | $229.94 |
Technical Indicators
Market Signals| Indicator | HMY | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 63.63 | 45.49 |
| Support Level | $20.10 | $192.28 |
| Resistance Level | $20.80 | $213.22 |
| Average True Range (ATR) | 0.81 | 10.39 |
| MACD | 0.07 | -0.84 |
| Stochastic Oscillator | 77.69 | 22.68 |
Price Performance
Historical ComparisonAbout HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.